Biotechnology
FDA grants full approval to Pfizer Covid treatment Paxlovid for high-risk adults
The Food and Drug Administration on Thursday granted full approval to Pfizer’s Covid antiviral pill, Paxlovid, for adults who are at high risk of getting severely sick with the virus. Paxlovid is specifically advised for the treatment of mild to moderate Covid in adults older than 50 and people who suffer from certain medical conditions […]
Read More
Scientists propose long Covid definition based on key symptoms in large study
South_agency | E+ | Getty Images Scientists funded by the federal government have proposed a definition of long Covid based on symptoms identified in a large study published Thursday in the Journal of the American Medical Association. The definition is based on 12 symptoms that most separate people with long Covid six months or more […]
Read More
New HIV infections decline in U.S. but most people at risk are not receiving prevention drugs
Callista Images | Image Source | Getty Images New HIV infections declined modestly in the U.S. over a four-year period but the nation is far from reaching its goal of ending the epidemic, according to the most recent data published by the Centers for Disease Control and Prevention on Tuesday. The overwhelming majority of people […]
Read More
Here’s what Pfizer and Moderna say is subsequent for their Covid vaccines
A pharmacist prepares to administer COVID-19 vaccine booster pictures through an function hosted by the Chicago Division of Public Health and fitness at the Southwest Senior Middle on September 09, 2022 in Chicago, Illinois. Scott Olson | Getty Pictures 3 several years and billions of Covid vaccinations into the pandemic, Pfizer and Moderna say their […]
Read More
Pfizer oral weight loss drug may be as effective as, quicker than Ozempic injection by Novo Nordisk, study says
Weight-loss drugs have become a hot topic as public heath authorities and pharmaceutical companies seek to find solutions to the growing global obesity epidemic. Florian Gaertner | Photothek | Getty Images An oral drug made by Pfizer causes a similar amount of weight loss as, and works quicker than, rival Novo Nordisk‘s blockbuster injection Ozempic, […]
Read More
FDA advisors recommend Pfizer’s RSV vaccine for infants but raise safety concerns
Respiratory syncytial virus – viral vaccine under research Hailshadow | Istock | Getty Images The Food and Drug Administration’s independent panel of advisors on Thursday recommended full approval of Pfizer’s vaccine that protects infants from RSV, but raised safety concerns over premature births that may be tied to the shot. The committee unanimously said the […]
Read More
CDC urges mpox vaccination among people at high risk to prevent summer surge
Bottle of Vaccine for booster shot for Smallpox and Monkeypox MPXV. Angelp | Istock | Getty Images The Centers for Disease Control and Prevention on Thursday urged gay men and other individuals at high risk from mpox to get fully vaccinated to prevent a summer resurgence of the virus. The CDC’s call for those at […]
Read More
Horizon Therapeutics says Amgen deal could close earlier than planned if FTC fails to block it
Robert Galbraith | Reuters Horizon Therapeutics expects its $27.8 billion sale to Amgen to close as early as the end of the third quarter, earlier than previously planned — if the Federal Trade Commission’s attempt to block the deal fails — according to a document filed Thursday with the Securities and Exchange Commission. The FTC […]
Read More
NJ Gov. Murphy would look at defying Supreme Courtroom if justices again abortion tablet ban
New Jersey Gov. Phil Murphy Scott Mlyn | CNBC New Jersey Gov. Phil Murphy on Wednesday claimed he would take into account defying the Supreme Court docket and go on to present mifepristone if the court docket guidelines in favor of a ban on the abortion capsule. When questioned if the point out would prescribe […]
Read More
Pfizer to raise $31 billion in debt offering to fund Seagen acquisition, SEC filing shows
A logo for Pfizer is displayed on a monitor on the floor at the New York Stock Exchange, July 29, 2019. Brendan McDermid | Reuters Pfizer plans to raise $31 billion through a debt offering to fund its proposed acquisition of cancer drugmaker Seagen, for what would be its largest takeover since 2009, according to […]
Read More